D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 67 Citations 12,418 306 World Ranking 5372 National Ranking 384

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Gene
  • Biochemistry

Manfred Jung spends much of his time researching Biochemistry, Histone deacetylase, Histone, NAD+ kinase and Histone methyltransferase. His research in Enzyme, Enzyme inhibitor, Sirtuin, Group III Histone Deacetylases and Docking are components of Biochemistry. His study focuses on the intersection of Histone deacetylase and fields such as Hydroxamic acid with connections in the field of Growth inhibition and Western blot.

His Histone research focuses on Transcription and how it connects with Zinc, Sirtuin 1 and Protein deacetylase. The study incorporates disciplines such as Phenotype, Cell, Small molecule and Yeast in addition to NAD+ kinase. The concepts of his Histone methyltransferase study are interwoven with issues in Cancer, Methyltransferase and Histone methylation.

His most cited work include:

  • Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy (325 citations)
  • SIRT1 regulates HIV transcription via Tat deacetylation. (264 citations)
  • Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy (209 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Biochemistry, Histone, Histone deacetylase, Epigenetics and Cancer research. Enzyme, NAD+ kinase, Sirtuin, Docking and In vitro are subfields of Biochemistry in which his conducts study. His Histone research also works with subjects such as

  • Acetylation which intersects with area such as HDAC6,
  • Cancer which is related to area like Pharmacology.

Histone deacetylase is closely attributed to Hydroxamic acid in his research. His Epigenetics research includes themes of Computational biology, Drug discovery and Cell biology. The various areas that he examines in his Cancer research study include Vorinostat, Cell culture, Leukemia and Histone deacetylase inhibitor.

He most often published in these fields:

  • Biochemistry (39.94%)
  • Histone (23.58%)
  • Histone deacetylase (20.44%)

What were the highlights of his more recent work (between 2018-2021)?

  • Epigenetics (20.75%)
  • Biochemistry (39.94%)
  • Cell biology (10.38%)

In recent papers he was focusing on the following fields of study:

His main research concerns Epigenetics, Biochemistry, Cell biology, Combinatorial chemistry and Histone. His Epigenetics research is multidisciplinary, incorporating elements of Drug action and Cancer research. His biological study spans a wide range of topics, including Triazole, Moiety and Sirtuin.

His research integrates issues of In vitro, Acetylation, Targeted drug delivery, Derivatization and Photoisomerization in his study of Histone. His Acetylation study deals with HDAC6 intersecting with Structure–activity relationship, Docking and HDAC8. As a part of the same scientific study, Manfred Jung usually deals with the Entinostat, concentrating on Albendazole and frequently concerns with Histone deacetylase.

Between 2018 and 2021, his most popular works were:

  • Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors (37 citations)
  • KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells. (21 citations)
  • LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML. (21 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Gene
  • DNA

His primary scientific interests are in Epigenetics, Regulation of gene expression, Cell biology, Biochemistry and Cancer research. His studies in Epigenetics integrate themes in fields like Autophagy, In vitro, Acetylation, Histone and Drug discovery. His study in the fields of Histone Demethylases under the domain of Histone overlaps with other disciplines such as Deferasirox.

As a part of the same scientific family, Manfred Jung mostly works in the field of Cell biology, focusing on Methylation and, on occasion, Prostate cancer and Histone H4. His research in Biochemistry intersects with topics in Drug detection and Phenothiazine. Manfred Jung interconnects Transcription factor, IRF8 and Conditional gene knockout in the investigation of issues within Cancer research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy

Julia M. Wagner;Björn Hackanson;Michael Lübbert;Manfred Jung.
Clinical Epigenetics (2010)

440 Citations

SIRT1 regulates HIV transcription via Tat deacetylation.

Sara Pagans;Angelika Pedal;Brian J North;Katrin Kaehlcke.
PLOS Biology (2005)

372 Citations

Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy

Ludovica Morera;Michael Lübbert;Manfred Jung.
Clinical Epigenetics (2016)

331 Citations

Inhibitors of Histone Deacetylase as New Anticancer Agents

Manfred Jung.
Current Medicinal Chemistry (2001)

277 Citations

Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.

Manfred Jung;Gerald Brosch;Doris Kölle;Hans Scherf.
Journal of Medicinal Chemistry (1999)

252 Citations

Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.

Tobias Rumpf;Matthias Schiedel;Berin Karaman;Claudia Roessler.
Nature Communications (2015)

214 Citations

Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins)

Johannes Trapp;Rene Meier;Darunee Hongwiset;Matthias U. Kassack.
ChemMedChem (2007)

206 Citations

HDAC8: a multifaceted target for therapeutic interventions

Alokta Chakrabarti;Ina Oehme;Olaf Witt;Guilherme Oliveira.
Trends in Pharmacological Sciences (2015)

200 Citations

Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)

Matthias Schiedel;Daniel Herp;Sören Hammelmann;Sören Swyter.
Journal of Medicinal Chemistry (2018)

192 Citations

The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors

Astrid Spannhoff;Astrid Spannhoff;Alexander‐Thomas Hauser;Ralf Heinke;Wolfgang Sippl.
ChemMedChem (2009)

184 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Manfred Jung

Antonello Mai

Antonello Mai

Sapienza University of Rome

Publications: 66

Lucia Altucci

Lucia Altucci

University of Campania "Luigi Vanvitelli"

Publications: 45

Dante Rotili

Dante Rotili

Sapienza University of Rome

Publications: 39

Takayoshi Suzuki

Takayoshi Suzuki

Osaka University

Publications: 33

Wolfgang Sippl

Wolfgang Sippl

Martin Luther University Halle-Wittenberg

Publications: 30

Cheng Luo

Cheng Luo

Chinese Academy of Sciences

Publications: 29

Cheryl H. Arrowsmith

Cheryl H. Arrowsmith

Structural Genomics Consortium

Publications: 23

Minoru Yoshida

Minoru Yoshida

University of Tokyo

Publications: 23

Saverio Minucci

Saverio Minucci

European Institute of Oncology

Publications: 22

Hening Lin

Hening Lin

Howard Hughes Medical Institute

Publications: 19

Clemens Steegborn

Clemens Steegborn

University of Bayreuth

Publications: 19

Melanie Ott

Melanie Ott

Gladstone Institutes

Publications: 18

Hualiang Jiang

Hualiang Jiang

Chinese Academy of Sciences

Publications: 18

Sergio Verjovski-Almeida

Sergio Verjovski-Almeida

Universidade de São Paulo

Publications: 18

Matthieu Schapira

Matthieu Schapira

University of Toronto

Publications: 18

Michael Reth

Michael Reth

University of Freiburg

Publications: 18

Trending Scientists

Ali N. Akansu

Ali N. Akansu

New Jersey Institute of Technology

Vincenzo Augugliaro

Vincenzo Augugliaro

University of Palermo

Hans-Jörg Fecht

Hans-Jörg Fecht

University of Ulm

Emil J. W. List

Emil J. W. List

Humboldt-Universität zu Berlin

Philippe Caroff

Philippe Caroff

Microsoft (United States)

Richard B. Fair

Richard B. Fair

Duke University

Karin Buiting

Karin Buiting

University of Duisburg-Essen

Catherine E. Lovelock

Catherine E. Lovelock

University of Queensland

Harri Hakkarainen

Harri Hakkarainen

University of Turku

Patricia Simon-Assmann

Patricia Simon-Assmann

Grenoble Alpes University

R. Manjunatha Kini

R. Manjunatha Kini

National University of Singapore

Björn Rasch

Björn Rasch

University of Fribourg

John C. Kappes

John C. Kappes

University of Alabama at Birmingham

Anthony F. Bogaert

Anthony F. Bogaert

Brock University

Torben Jørgensen

Torben Jørgensen

University of Copenhagen

F. Krennrich

F. Krennrich

Iowa State University

Something went wrong. Please try again later.